Generation of human parallel chimeric antigen receptor (pCAR) T cells to achieve synergistic T cell co-stimulation

STAR Protoc. 2022 May 21;3(2):101414. doi: 10.1016/j.xpro.2022.101414. eCollection 2022 Jun 17.

Abstract

Dual co-stimulation may be harnessed using parallel chimeric antigen receptors (pCARs) in which two distinct co-stimulatory units are adjacently localized on the plasma membrane. This protocol summarizes construct design, human T cell isolation, retroviral transduction, tissue culture expansion, and preclinical testing of pCAR T cells, exemplified by receptors that co-target avb6 integrin and ErbB dimers. For complete details on the use and execution of this protocol, please refer to Muliaditan et al. (2021).

Keywords: Cancer; Cell Biology; Cell isolation; Cell-based Assays; Flow Cytometry/Mass Cytometry; Immunology; Molecular Biology.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Humans
  • Receptors, Chimeric Antigen* / genetics
  • Retroviridae
  • T-Lymphocytes

Substances

  • Receptors, Chimeric Antigen